| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Optic Neuropathy, Ischemic | 21 | 2019 | 48 | 5.370 |
Why?
|
| Vision Disorders | 34 | 2020 | 216 | 3.990 |
Why?
|
| Papilledema | 22 | 2022 | 83 | 3.540 |
Why?
|
| Visual Fields | 30 | 2021 | 144 | 3.380 |
Why?
|
| Visual Acuity | 39 | 2022 | 707 | 2.530 |
Why?
|
| Optic Nerve Diseases | 14 | 2016 | 85 | 2.420 |
Why?
|
| Giant Cell Arteritis | 12 | 2019 | 57 | 2.420 |
Why?
|
| Visual Field Tests | 19 | 2021 | 52 | 1.960 |
Why?
|
| Temporal Arteries | 7 | 2019 | 39 | 1.840 |
Why?
|
| Blindness | 9 | 2012 | 76 | 1.650 |
Why?
|
| Scotoma | 3 | 2021 | 18 | 1.560 |
Why?
|
| Optic Nerve | 7 | 2019 | 114 | 1.280 |
Why?
|
| Ophthalmoplegia | 5 | 2017 | 56 | 1.250 |
Why?
|
| Blepharoptosis | 4 | 2023 | 63 | 1.250 |
Why?
|
| Eye | 5 | 2022 | 235 | 1.240 |
Why?
|
| Optic Disk | 9 | 2019 | 49 | 1.220 |
Why?
|
| Eye Diseases | 3 | 2020 | 117 | 1.200 |
Why?
|
| Retinal Artery Occlusion | 5 | 2017 | 15 | 1.180 |
Why?
|
| Intracranial Hypertension | 7 | 2022 | 133 | 1.150 |
Why?
|
| Optic Chiasm | 4 | 2016 | 14 | 1.080 |
Why?
|
| Tomography, Optical Coherence | 12 | 2019 | 490 | 1.050 |
Why?
|
| Magnetic Resonance Imaging | 36 | 2023 | 3831 | 1.030 |
Why?
|
| Hemianopsia | 5 | 2021 | 24 | 1.030 |
Why?
|
| Migraine Disorders | 5 | 2019 | 62 | 1.020 |
Why?
|
| Humans | 142 | 2025 | 132089 | 0.970 |
Why?
|
| Vigabatrin | 4 | 2018 | 17 | 0.930 |
Why?
|
| Diplopia | 9 | 2022 | 37 | 0.930 |
Why?
|
| Optic Neuritis | 5 | 2025 | 34 | 0.900 |
Why?
|
| Pupil Disorders | 2 | 2017 | 19 | 0.870 |
Why?
|
| Migraine with Aura | 4 | 2019 | 16 | 0.850 |
Why?
|
| Pseudotumor Cerebri | 3 | 2022 | 66 | 0.830 |
Why?
|
| Diagnosis, Differential | 19 | 2019 | 1952 | 0.780 |
Why?
|
| Mouthwashes | 1 | 2022 | 11 | 0.760 |
Why?
|
| Intracranial Aneurysm | 3 | 2012 | 90 | 0.750 |
Why?
|
| Choroid | 2 | 2019 | 36 | 0.730 |
Why?
|
| Hypervitaminosis A | 1 | 2021 | 1 | 0.710 |
Why?
|
| Dermatomyositis | 2 | 2015 | 34 | 0.680 |
Why?
|
| Retinal Vein Occlusion | 2 | 2015 | 28 | 0.680 |
Why?
|
| Moyamoya Disease | 1 | 2021 | 42 | 0.670 |
Why?
|
| Male | 72 | 2025 | 64967 | 0.660 |
Why?
|
| Fundus Oculi | 7 | 2019 | 64 | 0.640 |
Why?
|
| Ophthalmology | 2 | 2020 | 200 | 0.630 |
Why?
|
| Oculomotor Nerve Diseases | 4 | 2023 | 18 | 0.620 |
Why?
|
| Stroke | 3 | 2021 | 1085 | 0.610 |
Why?
|
| Female | 71 | 2025 | 70695 | 0.610 |
Why?
|
| Tooth Extraction | 1 | 2019 | 3 | 0.610 |
Why?
|
| Disease Transmission, Infectious | 1 | 2020 | 84 | 0.600 |
Why?
|
| Postoperative Complications | 7 | 2019 | 3142 | 0.590 |
Why?
|
| Central Serous Chorioretinopathy | 1 | 2018 | 8 | 0.580 |
Why?
|
| Fingolimod Hydrochloride | 1 | 2018 | 35 | 0.580 |
Why?
|
| Cystic Fibrosis | 1 | 2021 | 264 | 0.580 |
Why?
|
| Adult | 46 | 2022 | 31575 | 0.570 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 3 | 2010 | 83 | 0.570 |
Why?
|
| Orbital Diseases | 3 | 2022 | 72 | 0.570 |
Why?
|
| Brain Diseases | 3 | 2014 | 305 | 0.560 |
Why?
|
| Optic Atrophy, Hereditary, Leber | 3 | 2021 | 14 | 0.560 |
Why?
|
| Anemia | 2 | 2017 | 350 | 0.550 |
Why?
|
| Nervous System Diseases | 2 | 2019 | 408 | 0.550 |
Why?
|
| Middle Aged | 41 | 2023 | 28998 | 0.550 |
Why?
|
| Occipital Lobe | 3 | 2014 | 34 | 0.550 |
Why?
|
| Corneal Edema | 1 | 2017 | 11 | 0.540 |
Why?
|
| Perioperative Care | 1 | 2020 | 211 | 0.540 |
Why?
|
| Optic Tract | 1 | 2017 | 2 | 0.540 |
Why?
|
| Sinus Thrombosis, Intracranial | 5 | 2020 | 48 | 0.540 |
Why?
|
| Brain Neoplasms | 4 | 2023 | 1378 | 0.540 |
Why?
|
| Eye Abnormalities | 2 | 2012 | 104 | 0.530 |
Why?
|
| Cat-Scratch Disease | 4 | 2021 | 30 | 0.530 |
Why?
|
| Mydriasis | 1 | 2017 | 8 | 0.530 |
Why?
|
| Hyperhidrosis | 1 | 2017 | 10 | 0.530 |
Why?
|
| Anticonvulsants | 5 | 2016 | 390 | 0.530 |
Why?
|
| Carotid Artery, Internal | 2 | 2010 | 58 | 0.520 |
Why?
|
| Retina | 3 | 2018 | 490 | 0.520 |
Why?
|
| Eyelid Diseases | 1 | 2017 | 55 | 0.510 |
Why?
|
| Aged | 34 | 2022 | 21438 | 0.500 |
Why?
|
| Betacoronavirus | 1 | 2020 | 299 | 0.490 |
Why?
|
| Blindness, Cortical | 2 | 2006 | 15 | 0.490 |
Why?
|
| Pituitary Diseases | 1 | 2016 | 11 | 0.480 |
Why?
|
| Thyroid Diseases | 1 | 2016 | 29 | 0.480 |
Why?
|
| Decompression, Surgical | 2 | 2014 | 91 | 0.470 |
Why?
|
| Retinal Ganglion Cells | 3 | 2007 | 118 | 0.470 |
Why?
|
| Hypotension | 1 | 2017 | 185 | 0.460 |
Why?
|
| Behcet Syndrome | 1 | 2015 | 16 | 0.450 |
Why?
|
| Ocular Motility Disorders | 2 | 2006 | 38 | 0.450 |
Why?
|
| Coronavirus Infections | 1 | 2020 | 380 | 0.430 |
Why?
|
| Pneumonia, Viral | 1 | 2020 | 391 | 0.430 |
Why?
|
| Vestibular Diseases | 1 | 2015 | 67 | 0.420 |
Why?
|
| Syndrome | 6 | 2017 | 1174 | 0.420 |
Why?
|
| Cysts | 1 | 2014 | 97 | 0.420 |
Why?
|
| Recovery of Function | 2 | 2014 | 462 | 0.410 |
Why?
|
| Tremor | 1 | 2015 | 136 | 0.410 |
Why?
|
| Vision, Monocular | 2 | 2010 | 5 | 0.410 |
Why?
|
| Muscle Cramp | 1 | 2013 | 3 | 0.410 |
Why?
|
| POEMS Syndrome | 1 | 2013 | 2 | 0.410 |
Why?
|
| Arteriovenous Malformations | 2 | 2012 | 48 | 0.410 |
Why?
|
| Femoral Neoplasms | 1 | 2013 | 8 | 0.410 |
Why?
|
| Shock, Hemorrhagic | 2 | 2004 | 55 | 0.400 |
Why?
|
| Brain Injuries, Traumatic | 1 | 2017 | 302 | 0.400 |
Why?
|
| Retinal Diseases | 4 | 2010 | 179 | 0.400 |
Why?
|
| Immunosuppressive Agents | 5 | 2018 | 672 | 0.400 |
Why?
|
| Iris | 2 | 2010 | 43 | 0.390 |
Why?
|
| Optic Disk Drusen | 2 | 2009 | 3 | 0.390 |
Why?
|
| Tomography, X-Ray Computed | 11 | 2023 | 2169 | 0.380 |
Why?
|
| Cataract Extraction | 2 | 2005 | 152 | 0.380 |
Why?
|
| Exophthalmos | 3 | 2020 | 30 | 0.380 |
Why?
|
| Orbit | 3 | 2019 | 84 | 0.370 |
Why?
|
| Posterior Leukoencephalopathy Syndrome | 1 | 2012 | 22 | 0.370 |
Why?
|
| Pandemics | 1 | 2020 | 1183 | 0.370 |
Why?
|
| Brain Edema | 1 | 2012 | 70 | 0.360 |
Why?
|
| Magnetic Resonance Angiography | 5 | 2006 | 166 | 0.360 |
Why?
|
| Pigments, Biological | 1 | 2011 | 8 | 0.360 |
Why?
|
| Pigmentation | 1 | 2011 | 36 | 0.350 |
Why?
|
| Fluorescein Angiography | 6 | 2019 | 152 | 0.350 |
Why?
|
| Reflex, Pupillary | 1 | 2010 | 15 | 0.340 |
Why?
|
| Eye Injuries | 2 | 2019 | 44 | 0.340 |
Why?
|
| Ischemia | 2 | 2014 | 370 | 0.330 |
Why?
|
| Nystagmus, Pathologic | 2 | 2015 | 25 | 0.330 |
Why?
|
| Multiple Myeloma | 1 | 2013 | 204 | 0.330 |
Why?
|
| Pain | 3 | 2010 | 457 | 0.330 |
Why?
|
| Oculomotor Muscles | 2 | 2013 | 68 | 0.320 |
Why?
|
| Glioblastoma | 1 | 2014 | 363 | 0.320 |
Why?
|
| Apraxias | 1 | 2010 | 15 | 0.320 |
Why?
|
| Tuberculoma, Intracranial | 1 | 2009 | 7 | 0.320 |
Why?
|
| Nerve Fibers | 3 | 2007 | 76 | 0.320 |
Why?
|
| Aged, 80 and over | 12 | 2018 | 7104 | 0.320 |
Why?
|
| Physical Examination | 1 | 2010 | 165 | 0.310 |
Why?
|
| Photic Stimulation | 1 | 2010 | 228 | 0.310 |
Why?
|
| Tuberculosis, Meningeal | 1 | 2009 | 28 | 0.310 |
Why?
|
| Exotropia | 2 | 2023 | 18 | 0.310 |
Why?
|
| Eyelids | 1 | 2010 | 98 | 0.310 |
Why?
|
| Fatal Outcome | 3 | 2017 | 370 | 0.300 |
Why?
|
| Geniculate Bodies | 2 | 2021 | 11 | 0.290 |
Why?
|
| Carotid Stenosis | 1 | 2010 | 123 | 0.290 |
Why?
|
| Antitubercular Agents | 2 | 2009 | 264 | 0.290 |
Why?
|
| Hypertension, Pulmonary | 2 | 2010 | 460 | 0.290 |
Why?
|
| Prednisone | 7 | 2013 | 253 | 0.280 |
Why?
|
| Recurrence | 7 | 2011 | 1469 | 0.280 |
Why?
|
| Cerebral Angiography | 2 | 2006 | 107 | 0.280 |
Why?
|
| Retrospective Studies | 23 | 2025 | 17416 | 0.280 |
Why?
|
| Vasodilation | 2 | 2008 | 182 | 0.280 |
Why?
|
| Epoprostenol | 1 | 2007 | 43 | 0.270 |
Why?
|
| Risk Factors | 12 | 2020 | 10946 | 0.270 |
Why?
|
| Bartonella henselae | 4 | 2021 | 17 | 0.270 |
Why?
|
| Acute Disease | 5 | 2014 | 1160 | 0.260 |
Why?
|
| Vascular Diseases | 1 | 2009 | 150 | 0.260 |
Why?
|
| Fructose | 2 | 2008 | 62 | 0.260 |
Why?
|
| Uveomeningoencephalitic Syndrome | 1 | 2007 | 1 | 0.260 |
Why?
|
| Ethambutol | 1 | 2007 | 7 | 0.260 |
Why?
|
| Eye Infections, Fungal | 2 | 2014 | 73 | 0.260 |
Why?
|
| Abducens Nerve Diseases | 2 | 2004 | 12 | 0.260 |
Why?
|
| Orbital Cellulitis | 1 | 2007 | 14 | 0.260 |
Why?
|
| Uveitis | 1 | 2007 | 38 | 0.250 |
Why?
|
| Jejunoileal Bypass | 1 | 2006 | 4 | 0.250 |
Why?
|
| Glucocorticoids | 9 | 2013 | 386 | 0.250 |
Why?
|
| Vitamin A Deficiency | 1 | 2006 | 11 | 0.250 |
Why?
|
| Brain | 2 | 2017 | 3176 | 0.250 |
Why?
|
| Vasodilator Agents | 1 | 2007 | 207 | 0.250 |
Why?
|
| Myokymia | 1 | 2006 | 9 | 0.240 |
Why?
|
| Conjunctiva | 1 | 2007 | 186 | 0.240 |
Why?
|
| Short Bowel Syndrome | 1 | 2006 | 66 | 0.240 |
Why?
|
| Lasers | 2 | 2003 | 117 | 0.240 |
Why?
|
| Contact Lenses, Hydrophilic | 2 | 2007 | 21 | 0.240 |
Why?
|
| Vitreous Detachment | 3 | 2018 | 11 | 0.230 |
Why?
|
| Meninges | 1 | 2005 | 21 | 0.230 |
Why?
|
| Tongue Neoplasms | 1 | 2005 | 30 | 0.230 |
Why?
|
| Myelin-Oligodendrocyte Glycoprotein | 1 | 2025 | 35 | 0.230 |
Why?
|
| Cataract | 2 | 2005 | 168 | 0.230 |
Why?
|
| Optical Illusions | 1 | 2004 | 3 | 0.230 |
Why?
|
| Asparaginase | 1 | 2005 | 49 | 0.230 |
Why?
|
| Oxazolidinones | 1 | 2005 | 34 | 0.230 |
Why?
|
| Saccades | 1 | 2004 | 21 | 0.230 |
Why?
|
| Ethmoid Sinus | 1 | 2004 | 9 | 0.220 |
Why?
|
| Cranial Nerves | 1 | 2004 | 19 | 0.220 |
Why?
|
| Lipectomy | 1 | 2004 | 9 | 0.220 |
Why?
|
| Acetamides | 1 | 2005 | 48 | 0.220 |
Why?
|
| Lens Implantation, Intraocular | 2 | 2003 | 216 | 0.220 |
Why?
|
| Biological Products | 1 | 2007 | 137 | 0.220 |
Why?
|
| Epistaxis | 1 | 2004 | 12 | 0.220 |
Why?
|
| Orbital Pseudotumor | 1 | 2004 | 10 | 0.220 |
Why?
|
| Myasthenia Gravis | 2 | 2012 | 69 | 0.220 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 2009 | 496 | 0.220 |
Why?
|
| Hypophysectomy | 1 | 2004 | 20 | 0.220 |
Why?
|
| Sphenoid Sinus | 1 | 2004 | 11 | 0.220 |
Why?
|
| Ophthalmoscopy | 5 | 2020 | 34 | 0.220 |
Why?
|
| Choroid Diseases | 2 | 2019 | 22 | 0.220 |
Why?
|
| Iatrogenic Disease | 1 | 2005 | 132 | 0.220 |
Why?
|
| Otorhinolaryngologic Surgical Procedures | 1 | 2004 | 35 | 0.210 |
Why?
|
| Brain Infarction | 1 | 2004 | 30 | 0.210 |
Why?
|
| Vitreous Body | 2 | 2018 | 96 | 0.210 |
Why?
|
| Follow-Up Studies | 7 | 2019 | 5416 | 0.210 |
Why?
|
| Renal Dialysis | 3 | 2010 | 948 | 0.210 |
Why?
|
| Hyphema | 1 | 2003 | 1 | 0.210 |
Why?
|
| Brain Stem | 2 | 2019 | 119 | 0.210 |
Why?
|
| Catheterization, Central Venous | 1 | 2005 | 139 | 0.210 |
Why?
|
| Craniocerebral Trauma | 1 | 2025 | 140 | 0.210 |
Why?
|
| Lens Capsule, Crystalline | 1 | 2003 | 30 | 0.210 |
Why?
|
| Nasopharyngeal Neoplasms | 1 | 2023 | 61 | 0.210 |
Why?
|
| Evoked Potentials, Visual | 3 | 2017 | 34 | 0.200 |
Why?
|
| Meningitis, Cryptococcal | 2 | 2014 | 20 | 0.200 |
Why?
|
| Peripheral Nervous System Diseases | 1 | 2004 | 137 | 0.200 |
Why?
|
| Neoplasm Invasiveness | 1 | 2005 | 663 | 0.200 |
Why?
|
| Catheterization, Peripheral | 1 | 2005 | 130 | 0.200 |
Why?
|
| Tonic Pupil | 1 | 2003 | 5 | 0.200 |
Why?
|
| Siblings | 1 | 2004 | 202 | 0.200 |
Why?
|
| Ocular Hypertension | 1 | 2003 | 24 | 0.200 |
Why?
|
| Sclera | 1 | 2003 | 41 | 0.200 |
Why?
|
| Kidney Failure, Chronic | 2 | 2010 | 951 | 0.200 |
Why?
|
| Astrocytoma | 1 | 2023 | 107 | 0.200 |
Why?
|
| Retinitis | 2 | 2021 | 16 | 0.190 |
Why?
|
| Prostatectomy | 1 | 2004 | 359 | 0.190 |
Why?
|
| Demyelinating Diseases | 1 | 2002 | 70 | 0.190 |
Why?
|
| Lens, Crystalline | 1 | 2003 | 106 | 0.190 |
Why?
|
| Retinal Artery | 1 | 2002 | 16 | 0.190 |
Why?
|
| Interferon-alpha | 1 | 2004 | 246 | 0.190 |
Why?
|
| Anti-Infective Agents | 1 | 2005 | 270 | 0.190 |
Why?
|
| Surgical Procedures, Operative | 1 | 2005 | 223 | 0.190 |
Why?
|
| Optic Nerve Injuries | 1 | 2022 | 11 | 0.190 |
Why?
|
| Thrombocytosis | 1 | 2002 | 34 | 0.190 |
Why?
|
| Prognosis | 7 | 2022 | 5014 | 0.180 |
Why?
|
| Autoantibodies | 1 | 2025 | 456 | 0.180 |
Why?
|
| Electroretinography | 3 | 2016 | 121 | 0.180 |
Why?
|
| Embolism | 1 | 2002 | 46 | 0.180 |
Why?
|
| Hypertension | 1 | 2010 | 1396 | 0.180 |
Why?
|
| Aminophenols | 1 | 2021 | 10 | 0.180 |
Why?
|
| Benzodioxoles | 1 | 2021 | 11 | 0.180 |
Why?
|
| Dilatation, Pathologic | 3 | 2008 | 89 | 0.180 |
Why?
|
| Pyrrolidines | 1 | 2021 | 44 | 0.180 |
Why?
|
| Precursor Cell Lymphoblastic Leukemia-Lymphoma | 2 | 2006 | 814 | 0.170 |
Why?
|
| Carcinoma | 1 | 2023 | 299 | 0.170 |
Why?
|
| Quinolones | 1 | 2021 | 58 | 0.170 |
Why?
|
| Visual Pathways | 2 | 2014 | 84 | 0.170 |
Why?
|
| Drug Therapy, Combination | 6 | 2014 | 1179 | 0.170 |
Why?
|
| Gastrointestinal Hemorrhage | 1 | 2003 | 237 | 0.170 |
Why?
|
| Retinopathy of Prematurity | 1 | 2001 | 64 | 0.170 |
Why?
|
| Antirheumatic Agents | 1 | 2002 | 122 | 0.170 |
Why?
|
| Functional Laterality | 2 | 2015 | 192 | 0.170 |
Why?
|
| Fusarium | 1 | 2000 | 13 | 0.170 |
Why?
|
| Lenses, Intraocular | 1 | 2003 | 277 | 0.170 |
Why?
|
| Carotid-Cavernous Sinus Fistula | 1 | 2020 | 12 | 0.160 |
Why?
|
| Nerve Compression Syndromes | 2 | 2013 | 16 | 0.160 |
Why?
|
| Laser Coagulation | 1 | 2001 | 130 | 0.160 |
Why?
|
| Conjunctival Diseases | 1 | 2020 | 26 | 0.160 |
Why?
|
| Drug Combinations | 1 | 2021 | 280 | 0.160 |
Why?
|
| Basketball | 1 | 2019 | 2 | 0.160 |
Why?
|
| Mycobacterium tuberculosis | 2 | 2017 | 413 | 0.160 |
Why?
|
| Varicose Veins | 1 | 2000 | 29 | 0.160 |
Why?
|
| Indoles | 1 | 2021 | 201 | 0.160 |
Why?
|
| Corneal Ulcer | 1 | 2000 | 54 | 0.160 |
Why?
|
| Myopia, Degenerative | 1 | 2019 | 7 | 0.160 |
Why?
|
| Pyridines | 1 | 2021 | 249 | 0.160 |
Why?
|
| Remission, Spontaneous | 3 | 2004 | 69 | 0.160 |
Why?
|
| Carcinoma, Squamous Cell | 1 | 2005 | 767 | 0.160 |
Why?
|
| Child | 15 | 2025 | 25786 | 0.150 |
Why?
|
| Molar, Third | 1 | 2019 | 1 | 0.150 |
Why?
|
| Histiocytosis, Langerhans-Cell | 1 | 2022 | 241 | 0.150 |
Why?
|
| Cavernous Sinus | 2 | 2013 | 24 | 0.150 |
Why?
|
| Intracranial Pressure | 3 | 2015 | 212 | 0.150 |
Why?
|
| Mycoses | 1 | 2000 | 116 | 0.150 |
Why?
|
| Vision, Binocular | 1 | 2019 | 28 | 0.150 |
Why?
|
| Inflammatory Bowel Diseases | 1 | 2003 | 326 | 0.150 |
Why?
|
| Retinal Vessels | 2 | 2014 | 78 | 0.150 |
Why?
|
| GABA Agents | 1 | 2018 | 20 | 0.150 |
Why?
|
| Registries | 3 | 2016 | 1581 | 0.150 |
Why?
|
| Multiple Sclerosis | 2 | 2018 | 383 | 0.150 |
Why?
|
| Retinal Pigment Epithelium | 1 | 2018 | 38 | 0.150 |
Why?
|
| Pyrazoles | 1 | 2021 | 332 | 0.140 |
Why?
|
| Biopsy | 6 | 2019 | 1284 | 0.140 |
Why?
|
| Retinoschisis | 1 | 2018 | 4 | 0.140 |
Why?
|
| Antiviral Agents | 1 | 2004 | 822 | 0.140 |
Why?
|
| Embolization, Therapeutic | 1 | 2020 | 223 | 0.140 |
Why?
|
| Pregnancy Complications | 1 | 2002 | 552 | 0.130 |
Why?
|
| Phlebography | 3 | 2013 | 43 | 0.130 |
Why?
|
| False Positive Reactions | 2 | 2010 | 142 | 0.130 |
Why?
|
| Perioperative Period | 1 | 2017 | 52 | 0.130 |
Why?
|
| Tuberculin Test | 1 | 2017 | 122 | 0.130 |
Why?
|
| Antifungal Agents | 2 | 2014 | 312 | 0.130 |
Why?
|
| Epilepsy, Complex Partial | 1 | 2016 | 14 | 0.130 |
Why?
|
| Meningitis, Fungal | 1 | 2016 | 5 | 0.130 |
Why?
|
| Latent Tuberculosis | 1 | 2017 | 76 | 0.120 |
Why?
|
| Interferon-gamma Release Tests | 1 | 2017 | 89 | 0.120 |
Why?
|
| Coccidioidomycosis | 1 | 2016 | 11 | 0.120 |
Why?
|
| Administration, Oral | 1 | 2018 | 698 | 0.120 |
Why?
|
| Cryptococcus neoformans | 2 | 2014 | 23 | 0.120 |
Why?
|
| Antibodies, Monoclonal | 1 | 2002 | 1028 | 0.120 |
Why?
|
| Neurosurgical Procedures | 2 | 2017 | 314 | 0.120 |
Why?
|
| Antineoplastic Agents | 2 | 2006 | 1826 | 0.120 |
Why?
|
| Intraocular Pressure | 3 | 2015 | 128 | 0.120 |
Why?
|
| Esotropia | 2 | 2006 | 14 | 0.120 |
Why?
|
| Adolescent | 14 | 2025 | 20560 | 0.120 |
Why?
|
| United States Food and Drug Administration | 1 | 2016 | 160 | 0.120 |
Why?
|
| Neurology | 1 | 2017 | 117 | 0.120 |
Why?
|
| Ultrasonography, Doppler, Transcranial | 1 | 2015 | 111 | 0.120 |
Why?
|
| Cerebrospinal Fluid Pressure | 2 | 2013 | 18 | 0.120 |
Why?
|
| Antigens, Bacterial | 1 | 2017 | 323 | 0.120 |
Why?
|
| Cyclohexanecarboxylic Acids | 1 | 2015 | 18 | 0.120 |
Why?
|
| Olivary Nucleus | 1 | 2015 | 11 | 0.120 |
Why?
|
| Amines | 1 | 2015 | 38 | 0.110 |
Why?
|
| HIV Infections | 1 | 2007 | 2038 | 0.110 |
Why?
|
| Radiography | 2 | 2014 | 819 | 0.110 |
Why?
|
| Tomography, Emission-Computed | 1 | 2014 | 37 | 0.110 |
Why?
|
| Comorbidity | 1 | 2020 | 1611 | 0.110 |
Why?
|
| Time Factors | 4 | 2020 | 6448 | 0.110 |
Why?
|
| Neurologic Examination | 1 | 2015 | 202 | 0.110 |
Why?
|
| Cryptococcosis | 1 | 2014 | 45 | 0.110 |
Why?
|
| Young Adult | 6 | 2020 | 9958 | 0.110 |
Why?
|
| Reproducibility of Results | 3 | 2017 | 3011 | 0.110 |
Why?
|
| Pulvinar | 1 | 2014 | 4 | 0.110 |
Why?
|
| Spasms, Infantile | 1 | 2016 | 175 | 0.110 |
Why?
|
| gamma-Aminobutyric Acid | 1 | 2015 | 172 | 0.110 |
Why?
|
| Vitrectomy | 2 | 2018 | 91 | 0.110 |
Why?
|
| Combined Modality Therapy | 3 | 2007 | 1294 | 0.100 |
Why?
|
| Methotrexate | 2 | 2008 | 350 | 0.100 |
Why?
|
| Orbital Neoplasms | 2 | 2004 | 48 | 0.100 |
Why?
|
| Muscle Denervation | 1 | 2013 | 7 | 0.100 |
Why?
|
| Hydrocephalus | 1 | 2016 | 277 | 0.100 |
Why?
|
| Pituitary Neoplasms | 2 | 2023 | 78 | 0.100 |
Why?
|
| Cytochrome b Group | 1 | 1992 | 5 | 0.100 |
Why?
|
| NADH, NADPH Oxidoreductases | 1 | 1992 | 12 | 0.100 |
Why?
|
| Neuroimaging | 1 | 2016 | 377 | 0.100 |
Why?
|
| Methylprednisolone | 2 | 2003 | 98 | 0.090 |
Why?
|
| NADPH Oxidases | 1 | 1992 | 111 | 0.090 |
Why?
|
| Gestational Age | 2 | 2009 | 1224 | 0.090 |
Why?
|
| Mucocele | 1 | 2011 | 7 | 0.090 |
Why?
|
| Paranasal Sinus Diseases | 1 | 2011 | 16 | 0.090 |
Why?
|
| Predictive Value of Tests | 2 | 2010 | 2322 | 0.090 |
Why?
|
| Blood Sedimentation | 2 | 2019 | 29 | 0.090 |
Why?
|
| Eye Infections, Bacterial | 1 | 2011 | 86 | 0.090 |
Why?
|
| Phosphodiesterase 5 Inhibitors | 1 | 2010 | 36 | 0.080 |
Why?
|
| Sildenafil Citrate | 1 | 2010 | 57 | 0.080 |
Why?
|
| Venous Thrombosis | 2 | 2004 | 172 | 0.080 |
Why?
|
| Sulfones | 1 | 2010 | 73 | 0.080 |
Why?
|
| Epilepsy | 2 | 2016 | 889 | 0.080 |
Why?
|
| Neutrophils | 1 | 1992 | 361 | 0.080 |
Why?
|
| Mutation | 2 | 2021 | 6228 | 0.080 |
Why?
|
| Purines | 1 | 2010 | 113 | 0.080 |
Why?
|
| Cerebrospinal Fluid | 1 | 2009 | 98 | 0.080 |
Why?
|
| Treatment Outcome | 5 | 2018 | 13034 | 0.080 |
Why?
|
| Angiography | 1 | 2010 | 208 | 0.080 |
Why?
|
| Cerebral Ventricle Neoplasms | 1 | 2009 | 14 | 0.080 |
Why?
|
| Ergotamines | 1 | 2009 | 1 | 0.080 |
Why?
|
| Endarterectomy, Carotid | 1 | 2010 | 83 | 0.080 |
Why?
|
| Mitochondrial Diseases | 2 | 2009 | 147 | 0.080 |
Why?
|
| Tissue Adhesions | 1 | 2009 | 29 | 0.080 |
Why?
|
| Piperazines | 1 | 2010 | 257 | 0.070 |
Why?
|
| United States | 3 | 2019 | 11667 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2003 | 988 | 0.070 |
Why?
|
| Catheterization | 1 | 2010 | 241 | 0.070 |
Why?
|
| DNA, Bacterial | 1 | 2009 | 494 | 0.070 |
Why?
|
| Bariatric Surgery | 1 | 2010 | 139 | 0.070 |
Why?
|
| Blood Vessels | 1 | 2007 | 103 | 0.070 |
Why?
|
| Veins | 2 | 2008 | 104 | 0.070 |
Why?
|
| Meningioma | 1 | 2009 | 134 | 0.070 |
Why?
|
| Color Vision Defects | 1 | 2007 | 4 | 0.070 |
Why?
|
| Hypertensive Encephalopathy | 1 | 2006 | 5 | 0.070 |
Why?
|
| Intracranial Thrombosis | 1 | 2006 | 12 | 0.070 |
Why?
|
| Hypoxia, Brain | 1 | 2006 | 36 | 0.060 |
Why?
|
| Optic Atrophy, Autosomal Dominant | 2 | 2003 | 11 | 0.060 |
Why?
|
| Cerebral Veins | 1 | 2006 | 18 | 0.060 |
Why?
|
| Prospective Studies | 4 | 2019 | 6572 | 0.060 |
Why?
|
| Sleep | 1 | 2010 | 374 | 0.060 |
Why?
|
| Contracture | 1 | 2006 | 27 | 0.060 |
Why?
|
| Brain Stem Neoplasms | 1 | 2006 | 46 | 0.060 |
Why?
|
| Brain Ischemia | 1 | 2008 | 278 | 0.060 |
Why?
|
| DNA, Mitochondrial | 2 | 2021 | 242 | 0.060 |
Why?
|
| Risk Assessment | 3 | 2016 | 3739 | 0.060 |
Why?
|
| Eye Neoplasms | 1 | 2006 | 46 | 0.060 |
Why?
|
| Obesity | 2 | 2010 | 2395 | 0.060 |
Why?
|
| Lacrimal Apparatus Diseases | 1 | 2006 | 43 | 0.060 |
Why?
|
| Heparin | 2 | 2004 | 212 | 0.060 |
Why?
|
| Abducens Nerve | 1 | 2005 | 3 | 0.060 |
Why?
|
| Linezolid | 1 | 2005 | 27 | 0.060 |
Why?
|
| Brachial Artery | 1 | 2005 | 40 | 0.060 |
Why?
|
| Retinal Perforations | 1 | 2005 | 25 | 0.060 |
Why?
|
| Visual Cortex | 1 | 2006 | 120 | 0.060 |
Why?
|
| Radiotherapy, Adjuvant | 1 | 2005 | 167 | 0.060 |
Why?
|
| Disease Progression | 4 | 2020 | 2225 | 0.060 |
Why?
|
| Cranial Nerve Diseases | 1 | 2005 | 28 | 0.060 |
Why?
|
| Acetazolamide | 1 | 2004 | 28 | 0.060 |
Why?
|
| Retinal Hemorrhage | 1 | 2004 | 24 | 0.050 |
Why?
|
| Ligation | 1 | 2004 | 140 | 0.050 |
Why?
|
| Jugular Veins | 1 | 2004 | 75 | 0.050 |
Why?
|
| Carbonic Anhydrase Inhibitors | 1 | 2004 | 27 | 0.050 |
Why?
|
| Blood-Brain Barrier | 1 | 2005 | 156 | 0.050 |
Why?
|
| Lacrimal Apparatus | 1 | 2006 | 128 | 0.050 |
Why?
|
| Electrophysiology | 1 | 2004 | 269 | 0.050 |
Why?
|
| Catheters, Indwelling | 1 | 2005 | 157 | 0.050 |
Why?
|
| Intestine, Small | 1 | 2006 | 309 | 0.050 |
Why?
|
| Craniopharyngioma | 1 | 2023 | 33 | 0.050 |
Why?
|
| Pregnancy | 2 | 2009 | 7555 | 0.050 |
Why?
|
| Parenteral Nutrition | 1 | 2005 | 199 | 0.050 |
Why?
|
| Stents | 1 | 2010 | 869 | 0.050 |
Why?
|
| Ciliary Body | 1 | 2003 | 24 | 0.050 |
Why?
|
| Churg-Strauss Syndrome | 1 | 2003 | 20 | 0.050 |
Why?
|
| Neoplasms, Radiation-Induced | 1 | 2023 | 81 | 0.050 |
Why?
|
| Venous Pressure | 1 | 2003 | 11 | 0.050 |
Why?
|
| Anterior Eye Segment | 1 | 2003 | 24 | 0.050 |
Why?
|
| Pseudophakia | 1 | 2003 | 44 | 0.050 |
Why?
|
| Folic Acid Antagonists | 1 | 2003 | 17 | 0.050 |
Why?
|
| Iridectomy | 1 | 2003 | 4 | 0.050 |
Why?
|
| Arteries | 1 | 2004 | 222 | 0.050 |
Why?
|
| Video Recording | 1 | 2004 | 204 | 0.050 |
Why?
|
| Neural Inhibition | 1 | 2004 | 109 | 0.050 |
Why?
|
| Interferon beta-1a | 1 | 2002 | 20 | 0.050 |
Why?
|
| Amiodarone | 1 | 2003 | 47 | 0.050 |
Why?
|
| Interferon-beta | 1 | 2002 | 54 | 0.050 |
Why?
|
| Sarcoma, Synovial | 1 | 2002 | 22 | 0.050 |
Why?
|
| Temporal Lobe | 1 | 2003 | 118 | 0.050 |
Why?
|
| Sarcoidosis | 1 | 2003 | 57 | 0.050 |
Why?
|
| Macula Lutea | 1 | 2003 | 47 | 0.050 |
Why?
|
| Adenoma | 1 | 2004 | 146 | 0.050 |
Why?
|
| Cytarabine | 1 | 2022 | 102 | 0.050 |
Why?
|
| Skull Base Neoplasms | 1 | 2002 | 37 | 0.050 |
Why?
|
| Blood Pressure | 2 | 2006 | 1400 | 0.050 |
Why?
|
| Infliximab | 1 | 2002 | 69 | 0.050 |
Why?
|
| Platelet Count | 1 | 2002 | 139 | 0.050 |
Why?
|
| Ultrasonography, Doppler, Color | 1 | 2002 | 57 | 0.050 |
Why?
|
| Anticoagulants | 2 | 2004 | 609 | 0.050 |
Why?
|
| Leukocyte Count | 1 | 2002 | 251 | 0.050 |
Why?
|
| Ophthalmoscopes | 1 | 2001 | 5 | 0.050 |
Why?
|
| Glaucoma | 1 | 2002 | 79 | 0.050 |
Why?
|
| Glioma | 1 | 2006 | 529 | 0.050 |
Why?
|
| Age Factors | 1 | 2008 | 2916 | 0.040 |
Why?
|
| Infusions, Intravenous | 1 | 2003 | 547 | 0.040 |
Why?
|
| Anti-Arrhythmia Agents | 1 | 2003 | 226 | 0.040 |
Why?
|
| Sensitivity and Specificity | 2 | 2006 | 2140 | 0.040 |
Why?
|
| Adrenal Cortex Hormones | 1 | 2003 | 339 | 0.040 |
Why?
|
| Cerebellum | 1 | 2005 | 462 | 0.040 |
Why?
|
| Antineoplastic Combined Chemotherapy Protocols | 2 | 2006 | 1342 | 0.040 |
Why?
|
| Soft Tissue Neoplasms | 1 | 2002 | 127 | 0.040 |
Why?
|
| Cats | 1 | 2021 | 118 | 0.040 |
Why?
|
| Carcinoma, Non-Small-Cell Lung | 1 | 2004 | 333 | 0.040 |
Why?
|
| Adjuvants, Immunologic | 1 | 2002 | 391 | 0.040 |
Why?
|
| Hypercholesterolemia | 1 | 2003 | 237 | 0.040 |
Why?
|
| Rupture, Spontaneous | 1 | 2000 | 47 | 0.040 |
Why?
|
| Keratoplasty, Penetrating | 1 | 2000 | 52 | 0.040 |
Why?
|
| Europe | 1 | 2021 | 372 | 0.040 |
Why?
|
| Eye Protective Devices | 1 | 2019 | 8 | 0.040 |
Why?
|
| Ophthalmic Solutions | 1 | 2000 | 90 | 0.040 |
Why?
|
| Hepatitis C | 1 | 2004 | 386 | 0.040 |
Why?
|
| Birth Weight | 1 | 2001 | 350 | 0.040 |
Why?
|
| Tumor Necrosis Factor-alpha | 1 | 2002 | 664 | 0.040 |
Why?
|
| Orbital Fractures | 1 | 2019 | 33 | 0.040 |
Why?
|
| Cesarean Section | 1 | 2002 | 424 | 0.040 |
Why?
|
| Traction | 1 | 2018 | 9 | 0.040 |
Why?
|
| Case-Control Studies | 2 | 2003 | 3416 | 0.040 |
Why?
|
| Seizures | 1 | 2003 | 893 | 0.030 |
Why?
|
| Adenocarcinoma | 1 | 2004 | 1015 | 0.030 |
Why?
|
| Diabetes Mellitus, Type 1 | 1 | 2005 | 861 | 0.030 |
Why?
|
| Antibodies, Bacterial | 2 | 2011 | 406 | 0.030 |
Why?
|
| Algorithms | 1 | 2003 | 1722 | 0.030 |
Why?
|
| Vision Tests | 1 | 2016 | 29 | 0.030 |
Why?
|
| C-Reactive Protein | 1 | 2019 | 465 | 0.030 |
Why?
|
| Cornea | 1 | 2000 | 570 | 0.030 |
Why?
|
| Ventriculoperitoneal Shunt | 1 | 2016 | 58 | 0.030 |
Why?
|
| Spinal Puncture | 1 | 2015 | 52 | 0.030 |
Why?
|
| Equipment Design | 1 | 2017 | 603 | 0.030 |
Why?
|
| Prostatic Neoplasms | 1 | 2004 | 1576 | 0.030 |
Why?
|
| Anti-Bacterial Agents | 2 | 2021 | 2555 | 0.030 |
Why?
|
| Cryptococcus gattii | 1 | 2014 | 2 | 0.030 |
Why?
|
| Flucytosine | 1 | 2014 | 17 | 0.030 |
Why?
|
| Antibodies, Fungal | 1 | 2014 | 13 | 0.030 |
Why?
|
| Antigens, Fungal | 1 | 2014 | 34 | 0.030 |
Why?
|
| Lung Neoplasms | 1 | 2004 | 1538 | 0.030 |
Why?
|
| Amphotericin B | 1 | 2014 | 91 | 0.030 |
Why?
|
| ROC Curve | 1 | 2015 | 601 | 0.030 |
Why?
|
| N-Formylmethionine Leucyl-Phenylalanine | 1 | 1992 | 8 | 0.020 |
Why?
|
| Transcobalamins | 1 | 1992 | 4 | 0.020 |
Why?
|
| Cell-Free System | 1 | 1992 | 64 | 0.020 |
Why?
|
| Spectrophotometry | 1 | 1992 | 56 | 0.020 |
Why?
|
| Phorbol Esters | 1 | 1992 | 21 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2016 | 1132 | 0.020 |
Why?
|
| NADP | 1 | 1992 | 54 | 0.020 |
Why?
|
| Infant | 2 | 2016 | 13061 | 0.020 |
Why?
|
| Alkaline Phosphatase | 1 | 1992 | 97 | 0.020 |
Why?
|
| Superoxides | 1 | 1992 | 133 | 0.020 |
Why?
|
| Cytosol | 1 | 1992 | 144 | 0.020 |
Why?
|
| Cytoplasmic Granules | 1 | 1992 | 49 | 0.020 |
Why?
|
| Atrophy | 1 | 2013 | 252 | 0.020 |
Why?
|
| Strabismus | 1 | 2013 | 54 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2016 | 1573 | 0.020 |
Why?
|
| Incidence | 1 | 2019 | 3379 | 0.020 |
Why?
|
| Point Mutation | 1 | 2013 | 348 | 0.020 |
Why?
|
| Oxidation-Reduction | 1 | 1992 | 436 | 0.020 |
Why?
|
| Fluorescent Antibody Technique, Indirect | 1 | 2011 | 101 | 0.020 |
Why?
|
| Likelihood Functions | 1 | 2011 | 120 | 0.020 |
Why?
|
| Kinetics | 1 | 1992 | 1129 | 0.020 |
Why?
|
| Cell Membrane | 1 | 1992 | 470 | 0.020 |
Why?
|
| Color Perception Tests | 1 | 2009 | 2 | 0.020 |
Why?
|
| Vision, Low | 1 | 2008 | 15 | 0.020 |
Why?
|
| Laminectomy | 1 | 2008 | 24 | 0.020 |
Why?
|
| Prone Position | 1 | 2008 | 33 | 0.020 |
Why?
|
| Infant, Newborn | 1 | 2001 | 8549 | 0.020 |
Why?
|
| Chronic Disease | 1 | 2013 | 1234 | 0.020 |
Why?
|
| Lumbar Vertebrae | 1 | 2008 | 113 | 0.020 |
Why?
|
| Amlodipine | 1 | 2006 | 23 | 0.020 |
Why?
|
| Valsartan | 1 | 2006 | 28 | 0.020 |
Why?
|
| Metoprolol | 1 | 2006 | 21 | 0.020 |
Why?
|
| Cross-Sectional Studies | 1 | 2015 | 3766 | 0.020 |
Why?
|
| Tetrazoles | 1 | 2006 | 69 | 0.020 |
Why?
|
| Valine | 1 | 2006 | 111 | 0.020 |
Why?
|
| Tissue Fixation | 1 | 2006 | 40 | 0.020 |
Why?
|
| Weight Loss | 1 | 2010 | 516 | 0.020 |
Why?
|
| Quinazolines | 1 | 2006 | 176 | 0.010 |
Why?
|
| Photography | 1 | 2005 | 86 | 0.010 |
Why?
|
| Retinal Detachment | 1 | 2005 | 71 | 0.010 |
Why?
|
| Biopsy, Fine-Needle | 1 | 2004 | 119 | 0.010 |
Why?
|
| Azathioprine | 1 | 2003 | 38 | 0.010 |
Why?
|
| Sural Nerve | 1 | 2003 | 47 | 0.010 |
Why?
|
| Antihypertensive Agents | 1 | 2006 | 429 | 0.010 |
Why?
|
| Color Perception | 1 | 2003 | 12 | 0.010 |
Why?
|
| Antibodies, Anticardiolipin | 1 | 2002 | 4 | 0.010 |
Why?
|
| Lupus Coagulation Inhibitor | 1 | 2002 | 7 | 0.010 |
Why?
|
| Forearm | 1 | 2002 | 39 | 0.010 |
Why?
|
| Antibodies, Antinuclear | 1 | 2002 | 31 | 0.010 |
Why?
|
| Headache | 1 | 2002 | 110 | 0.010 |
Why?
|
| GTP Phosphohydrolases | 1 | 2002 | 156 | 0.010 |
Why?
|
| Warfarin | 1 | 2002 | 129 | 0.010 |
Why?
|
| Cholesterol | 1 | 2003 | 558 | 0.010 |
Why?
|
| Animals | 1 | 2021 | 34798 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2002 | 803 | 0.010 |
Why?
|
| Neoplasm Recurrence, Local | 1 | 2006 | 1305 | 0.010 |
Why?
|
| Child, Preschool | 1 | 2011 | 14749 | 0.010 |
Why?
|